The Science

Evidence quality is the variable that determines target success

Most target failures trace back to shallow or poorly classified evidence. Avenzo applies a structured evidence taxonomy and scoring model to separate high-confidence targets from superficially supported ones.

Evidence Taxonomy

A four-tier classification of oncology evidence

Not all evidence is equal. Avenzo classifies every piece of evidence ingested into one of four tiers based on study design, reproducibility, and translational proximity. Tier weights are applied during composite scoring.

Tier Evidence type Weight in scoring
T1 Validated in multiple independent preclinical models with consistent direction High
T2 Single preclinical model or replicated cell-line data, clear mechanistic rationale Moderate-high
T3 Computational prediction or single-source literature with limited replication Moderate
T4 Indirect association, pathway-level inference, or low-n observational data Low

Scoring Model

How a composite score is assembled

A target's final score integrates all collected evidence through a three-step process. Each step applies independent logic so that bias in one dimension does not inflate the composite.

1
Tier-weighted aggregation

Individual evidence records are weighted by tier and aggregated per evidence dimension. A target supported by many T1 records scores higher than one with numerous T4 records on the same dimension.

2
Cross-dimension integration

Dimension scores for preclinical literature, clinical context alignment, and computational convergence are integrated using a bounded weighting formula. Dimensions that converge reinforce each other; divergent signals reduce confidence.

3
Confidence calibration

A confidence calibration pass adjusts for corpus coverage gaps. Targets with sparse overall evidence receive a coverage penalty, preventing high-dimensional scores built on shallow records from appearing over-ranked.

Validation Approach

How the model is tested against known outcomes

Avenzo evaluates scoring performance using a held-out validation set of targets with known downstream outcomes. Targets are scored as if by a team conducting initial prioritization, then compared to what the evidence record at that time could have predicted.

The validation framework focuses on ranking fidelity: does the model order high-outcome targets consistently above low-outcome ones? A separate retrospective analysis tracks ranking stability over time as evidence accumulates.

74%
of targets in the top quartile of Avenzo evidence scores matched known high-outcome outcomes in our benchmark set
Internal retrospective benchmark, early-access beta, held-out set of published outcomes

Get Started

Apply evidence depth to your current target list

Request early access to run your own target list through the Avenzo scoring pipeline and receive a structured evidence report.